发明公开
EP2187906A2 USE OF A FIBRINOGEN RECEPTOR ANTAGONIST AND/OR FOLLICULAR GONADOTROPIN RELEASING PEPTIDE AS A THERAPEUTIC AGENT IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIA INFECTION
审中-公开
使用血纤维蛋白原受体拮抗剂和/或卵泡促性腺激素释放肽的治疗剂感染链球菌肺炎的治疗
- 专利标题： USE OF A FIBRINOGEN RECEPTOR ANTAGONIST AND/OR FOLLICULAR GONADOTROPIN RELEASING PEPTIDE AS A THERAPEUTIC AGENT IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIA INFECTION
- 专利标题（中）： 使用血纤维蛋白原受体拮抗剂和/或卵泡促性腺激素释放肽的治疗剂感染链球菌肺炎的治疗
-
申请号： EP08802095.3申请日： 2008-09-09
-
公开(公告)号： EP2187906A2公开(公告)日： 2010-05-26
- 发明人: BEVEC, Dorian , CAVALLI, Fabio , CAVALLI, Vera , BACHER, Gerald
- 申请人： Mondobiotech Laboratories AG
- 申请人地址： Herrengasse 21 9490 Vaduz LI
- 专利权人： Mondobiotech Laboratories AG
- 当前专利权人： Mondobiotech Laboratories AG
- 当前专利权人地址： Herrengasse 21 9490 Vaduz LI
- 代理机构： Arth, Hans-Lothar
- 优先权： EP07017748 20070911
- 国际公布： WO2009039988 20090402
- 主分类号： A61K38/07
- IPC分类号： A61K38/07 ; A61K38/10 ; A61P31/04 ; A61P3/00 ; A61P9/00 ; A61P11/00 ; A61P25/28 ; A61P31/00 ; A61P35/00 ; A61P37/00
摘要：
The present invention is directed to the use of the peptide compound Lys-Lys-GIy-Glu-OH as a therapeutic agent for the prophylaxis and/or treatment of cancer, autoimmune diseases, fibrotic diseases, inflammatory diseases, neurodegenerative diseases, infectious diseases, lung diseases, heart and vascular diseases and metabolic diseases. Moreover the present invention relates to pharmaceutical compositions preferably in form of a lyophilisate or liquid buffer solution or artificial mother milk formulation or mother milk substitute containing the peptide Lys-Lys-Gly-Glu-OH optionally together with at least one pharmaceutically acceptable carrier, cryoprotectant, lyoprotectant, excipient and/or diluent.
信息查询
IPC分类:
